Vanguard Group Inc Vanda Pharmaceuticals Inc. Transaction History

Vanguard Group Inc

  • $5.37 Trillion
  • Q1 2025

A detailed history of Vanguard Group Inc transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,495,284 shares of VNDA stock, worth $15.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,495,284
Previous 3,506,287 0.31%
Holding current value
$15.2 Million
Previous $16.8 Million 4.48%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$4.31 - $5.13 $47,422 - $56,445
-11,003 Reduced 0.31%
3,495,284 $16 Million
Q4 2024

Feb 11, 2025
SELL
$4.41 - $5.46 $551,258 - $682,510
-125,002 Reduced 3.44%
3,506,287 $16.8 Million
Q3 2024

Nov 13, 2024
BUY
$4.61 - $6.34 $920,238 - $1.27 Million
199,618 Added 5.82%
3,631,289 $17 Million
Q2 2024

Aug 13, 2024
BUY
$3.91 - $6.5 $141,104 - $234,572
36,088 Added 1.06%
3,431,671 $19.4 Million
Q1 2024

May 10, 2024
SELL
$3.47 - $4.61 $209,948 - $278,923
-60,504 Reduced 1.75%
3,395,583 $14 Million
Q4 2023

Feb 14, 2024
SELL
$3.38 - $4.58 $64,912 - $87,958
-19,205 Reduced 0.55%
3,456,087 $14.6 Million
Q3 2023

Nov 14, 2023
SELL
$4.28 - $6.57 $3.26 Million - $5.01 Million
-762,144 Reduced 17.99%
3,475,292 $15 Million
Q2 2023

Aug 14, 2023
BUY
$5.9 - $6.95 $644,999 - $759,787
109,322 Added 2.65%
4,237,436 $27.9 Million
Q1 2023

May 15, 2023
BUY
$6.18 - $7.99 $840,158 - $1.09 Million
135,948 Added 3.41%
4,128,114 $28 Million
Q4 2022

Feb 10, 2023
BUY
$6.87 - $10.96 $670,594 - $1.07 Million
97,612 Added 2.51%
3,992,166 $29.5 Million
Q3 2022

Nov 14, 2022
BUY
$9.44 - $11.76 $536,399 - $668,226
56,822 Added 1.48%
3,894,554 $38.5 Million
Q2 2022

Aug 12, 2022
BUY
$9.31 - $11.84 $576,205 - $732,789
61,891 Added 1.64%
3,837,732 $41.8 Million
Q1 2022

May 13, 2022
SELL
$10.84 - $16.55 $1.09 Million - $1.67 Million
-100,843 Reduced 2.6%
3,775,841 $42.7 Million
Q4 2021

Feb 14, 2022
SELL
$15.69 - $21.14 $1.72 Million - $2.31 Million
-109,444 Reduced 2.75%
3,876,684 $60.8 Million
Q3 2021

Nov 12, 2021
SELL
$15.35 - $21.27 $1.69 Million - $2.34 Million
-109,950 Reduced 2.68%
3,986,128 $68.3 Million
Q2 2021

Aug 13, 2021
BUY
$15.71 - $21.51 $64.3 Million - $88.1 Million
4,096,078 New
4,096,078 $88.1 Million

Others Institutions Holding VNDA

# of Institutions
158
Shares Held
44.7M
Call Options Held
64.8K
Put Options Held
562K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $245M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email